Millennium Management’s Immunomedics Inc IMMU Stock Holding History

Millennium Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-112,600	Closed	-$9.57K	–	5848
2020 Q3	$9.57K	Buy	112,600 +32,600	+41%	+$1.65M	0.01%	1297
2020 Q2	$2.83M	Buy	80,000 +10,000	+14%	+$292K	﹤0.01%	2271
2020 Q1	$944K	Buy	+70,000	New	+$1.18M	﹤0.01%	2504
2019 Q2	–	Sell	-200,000	Closed	-$3.84M	–	4683
2019 Q1	$3.84M	Sell	200,000 -30,000	-13%	-$484K	0.01%	1943
2018 Q4	$3.28M	Buy	+230,000	New	+$4.57M	0.01%	1872
2018 Q1	–	Sell	-90,000	Closed	-$1.45M	–	4259
2017 Q4	$1.45M	Buy	+90,000	New	+$1.06M	﹤0.01%	2471
2015 Q3	–	Sell	-1,200,000	Closed	-$4.87M	–	3856
2015 Q2	$4.87M	Buy	1,200,000 +700,000	+140%	+$2.86M	0.01%	1416
2015 Q1	$1.92M	Buy	+500,000	New	+$2.17M	﹤0.01%	1977

Millennium Management's IMMU Position: Q4 2020 in Review

Millennium Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 2,750,749 shares — an estimated $234K sold.

Millennium Management first reported a position in IMMU in Q2 2013 and held it in 24 quarters. The position peaked at $102M in Q4 2017. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Millennium Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Millennium Management sold 2,750,749 Immunomedics Inc shares in Q4 2020, an estimated $234K.
Millennium Management first reported a position in Immunomedics Inc in Q2 2013 and held it in 24 quarters.
Millennium Management's Immunomedics Inc position peaked at $102M in Q4 2017.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Millennium Management's 13F filing for Q4 2020, filed 16 Feb 2021.